142 related articles for article (PubMed ID: 25652378)
1. [Influential factors for theraputic effect of steroid on adult primary nephrotic syndrome].
Chen C; Xia Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jan; 40(1):78-82. PubMed ID: 25652378
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions.
Tejani A; Phadke K; Nicastri A; Adamson O; Chen CK; Trachtman H; Tejani C
Nephron; 1985; 41(2):170-3. PubMed ID: 4047274
[TBL] [Abstract][Full Text] [Related]
3. Minimal change disease and focal segmental glomerulosclerosis in adults: response to steroids and risk of renal failure.
Moura LR; Franco MF; Kirsztajn GM
J Bras Nefrol; 2015; 37(4):475-80. PubMed ID: 26648497
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of primary nephrotic syndrome in Egyptian children.
Kaddah A; Sabry S; Emil E; El-Refaey M
J Nephrol; 2012; 25(5):732-7. PubMed ID: 22101675
[TBL] [Abstract][Full Text] [Related]
5. Correlation of fractional excretion of magnesium with steroid responsiveness in children with nephrotic syndrome.
Rumana J; Hanif M; Muinuddin G; Maruf-Ul-Quader M
Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):830-6. PubMed ID: 24969196
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
7. A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis.
Hirose M; Nishino T; Uramatsu T; Obata Y; Kitamura M; Kawazu T; Miyazaki M; Taguchi T; Kohno S
Clin Exp Nephrol; 2012 Jun; 16(3):473-9. PubMed ID: 22258558
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome.
Westhoff TH; Schmidt S; Zidek W; Beige J; van der Giet M
Clin Nephrol; 2006 Jun; 65(6):393-400. PubMed ID: 16792133
[TBL] [Abstract][Full Text] [Related]
10. Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.
Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Takeda A; Tsukamoto T; Uchida S; Tsuruya K; Shoji T; Hayashi H; Akai Y; Fukunaga M; Konta T; Nishio S; Goto S; Tamai H; Nagai K; Katafuchi R; Masutani K; Wada T; Nishino T; Shirasaki A; Sobajima H; Nitta K; Yamagata K; Kazama JJ; Hiromura K; Yasuda H; Mizutani M; Akahori T; Naruse T; Hiramatsu T; Morozumi K; Mimura T; Saka Y; Ishimura E; Hasegawa H; Ichikawa D; Shigematsu T; Sato H; Narita I; Isaka Y;
J Nephrol; 2022 May; 35(4):1135-1144. PubMed ID: 35366214
[TBL] [Abstract][Full Text] [Related]
11. T cell subsets in glomerulonephritis.
Lin CY; Yang YM; Fu YK
Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514
[TBL] [Abstract][Full Text] [Related]
12. High Serum Endothelin-1 Level is Associated with Poor Response to Steroid Therapy in Childhood-Onset Nephrotic Syndrome.
Ahmed HM; Morgan DS; Doudar NA; Naguib MS
Saudi J Kidney Dis Transpl; 2019; 30(4):769-774. PubMed ID: 31464232
[TBL] [Abstract][Full Text] [Related]
13. [Idiopathic Nephrotic Syndrome: recommendations of the Nephrology Branch of the Chilean Society of Pediatrics. Part One].
Hevia P; Nazal V; Rosati MP; Quiroz L; Alarcón C; Márquez S; Cuevas K;
Rev Chil Pediatr; 2015; 86(4):291-8. PubMed ID: 26362970
[TBL] [Abstract][Full Text] [Related]
14. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
[TBL] [Abstract][Full Text] [Related]
15. Histopathological Spectrum and Short-Term Outcome of Treatment with Cyclophosphamide in Relapsing Steroid-Sensitive Nephrotic Syndrome.
Bajeer IA; Khatri S; Tresa V; Hashmi S; Mubarak M; Lanewala AA
J Coll Physicians Surg Pak; 2018 Jun; 28(6):436-439. PubMed ID: 29848418
[TBL] [Abstract][Full Text] [Related]
16. Renal disease. II. The treatment of minimal change nephropathy and focal segmental glomerulosclerosis.
Mason PD
J R Coll Physicians Lond; 1997; 31(2):137-41. PubMed ID: 9131509
[No Abstract] [Full Text] [Related]
17. Clinical outcomes of nephrotic syndrome in immunoglobulin a nephropathy.
Jeong EG; Hyoun S; Lee SM; An WS; Kim SE; Son YK
Saudi J Kidney Dis Transpl; 2017; 28(6):1314-1320. PubMed ID: 29265042
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease.
Qin J; Yang Q; Tang X; Chen W; Li Z; Mao H; Jiang Z; Huang F; Yu X
Clin Nephrol; 2013 Jan; 79(1):37-44. PubMed ID: 22948116
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine in idiopathic nephrotic syndrome.
Ponticelli C
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
[TBL] [Abstract][Full Text] [Related]
20. The increasing incidence of initial steroid resistance in childhood nephrotic syndrome.
Banaszak B; Banaszak P
Pediatr Nephrol; 2012 Jun; 27(6):927-32. PubMed ID: 22231438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
